Close Menu

The Scan

Reuters reports that France's sewage surveillance has found COVID-19 to be spreading quickly in three cities.

Japan is expected to approve the Pfizer-BioNTech SARS-CoV-2 vaccine Sunday, according to Bloomberg.

In Science this week: functional importance of NOVA1 in human evolution, and more.

Take a Load Off?

An initial analysis suggests the Pfizer-BioNTech vaccine could reduce viral load, the Guardian reports.

A new genome-wide association study in Nature Communications uncovers five dozen loci linked to frequency of afternoon naps.

Possible Early Cases

World Health Organization investigators have uncovered possible early cases of COVID-19 in central China, the Wall Street Journal reports.

In Nature this week: TOPMed analysis of diverse human genomes, and more.

Even More Testing

NPR reports that though the Biden Administration is moving to scale up COVID-19 testing, experts say even more is needed.

Need to Share

Nature writes about efforts to promote data sharing in genomics.

Path Forward Someday

The Washington Post writes that vaccinations and vigilance provide a "labyrinthine" path forward from the pandemic.

In Genome Research this week: selection on cognition genes in primates, algorithm to find gene fusions, and more.

Letters from scientists and civil rights leaders seek an investigation of racial profiling complaints stemming from the Department of Justice's China Initiative, according to Science.

The Economist reports that a single genetic change could have enabled vertebrates to leave the water.

The World Health Organization team conducting an investigation into SARS-CoV-2 origins says bats remain its likely source, according to Reuters.

In PNAS this week: placental expression risk scores for schizophrenia, ancient DNA-based analysis of human arrival in China, and more.

A preprint indicates that the SARS-CoV-2 variant identified in the UK is spreading rapidly in the US, the Washington Post reports.

For Quick Updates

The US Food and Drug Administration is looking into enabling SARS-CoV-2 vaccine developers to quickly update them to cope with new viral variants, Business Insider reports.

A small study suggests fecal transplants could increase the number of cancer patients who respond to immunotherapy, according to LiveScience.

In PLOS this week: transcriptome-wide analysis of autism spectrum disorder, diversity of Staphylococcus from infected joint prosthetics, and more.

CNN reports Johnson & Johnson is seeking an emergency authorization for its SARS-CoV-2 vaccine in the US.

Appeal Lost

According to Retraction Watch, Carlo Croce, an Ohio State University cancer researcher, has lost his latest court appeal.

23andMe Going Public

Direct-to-consumer genetic testing company 23andMe is undergoing a merger with the goal of becoming publicly traded.

In Science this week: knocking down an autism-linked gene in young birds influences learning new songs, more.

Half the Size

The US Department of Agriculture research agencies that relocated to Kansas City are smaller than they used to be, NPR reports.

Just Breathe

The Netherlands is to offer a rapid breath-test for SARS-CoV-2, according to Reuters.

Pages

NPR reports that researchers have developed chimeric embryos as part of work toward growing human organs in animals for organ transplants.

According to the Washington Post, the Biden Administration is set to make changes to federal restrictions on fetal tissue research.

In Science this week: approach to isolated trace DNA from archaic humans from sediments, and more.

Texas Monthly looks into the DNA Zoo being collected by Baylor College of Medicine researchers.